lomerizine has been researched along with Conjugate Nystagmus in 1 studies
lomerizine: used to treat migraines
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lomerizine, a calcium channel blocker, may be effective as a treatment for migraine-associated vertigo (MAV)." | 9.12 | Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. ( Chihara, Y; Ito, K; Iwasaki, S; Murofushi, T; Sugasawa, K; Ushio, M, 2007) |
| "Lomerizine, a calcium channel blocker, may be effective as a treatment for migraine-associated vertigo (MAV)." | 5.12 | Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. ( Chihara, Y; Ito, K; Iwasaki, S; Murofushi, T; Sugasawa, K; Ushio, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwasaki, S | 1 |
| Ushio, M | 1 |
| Chihara, Y | 1 |
| Ito, K | 1 |
| Sugasawa, K | 1 |
| Murofushi, T | 1 |
1 trial available for lomerizine and Conjugate Nystagmus
| Article | Year |
|---|---|
Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist.
Topics: Adolescent; Adult; Asian People; Calcium Channel Blockers; Evoked Potentials; Female; Humans; Male; | 2007 |